Macquarie Group
BNTX icon

Macquarie Group’s BioNTech BNTX Stock Holding History

Macquarie Group’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-231,461
Closed -$22.8M – 947
2025
Q3 		$22.8M Buy
231,461
+39,913
+21% +$4.27M 0.03% 634
2025
Q2 		$20.1M Buy
191,548
+1,296
+0.7% +$131K 0.02% 667
2025
Q1 		$17.2M Sell
190,252
-44,793
-19% -$5.02M 0.02% 704
2024
Q4 		$26.8M Buy
235,045
+197,782
+531% +$22.6M 0.03% 587
2024
Q3 		$4.43M Hold
37,263
– – ﹤0.01% 996
2024
Q2 		$2.99M Hold
37,263
– – ﹤0.01% 1104
2024
Q1 		$3.44M Sell
37,263
-1,141
-3% -$109K ﹤0.01% 1068
2023
Q4 		$4.05M Sell
38,404
-2,342
-6% -$236K ﹤0.01% 1016
2023
Q3 		$4.43M Hold
40,746
– – 0.01% 954
2023
Q2 		$4.4M Buy
40,746
+3,752
+10% +$422K 0.01% 957
2023
Q1 		$4.61M Sell
36,994
-3,894
-10% -$535K 0.01% 947
2022
Q4 		$6.14M Buy
40,888
+23,375
+133% +$3.6M 0.01% 941
2022
Q3 		$2.36M Buy
17,513
+1,065
+6% +$163K ﹤0.01% 1171
2022
Q2 		$2.45M Buy
16,448
+1,156
+8% +$177K ﹤0.01% 1235
2022
Q1 		$2.61M Buy
15,292
+6,973
+84% +$1.17M ﹤0.01% 1292
2021
Q4 		$2.15M Buy
+8,319
New +$2.28M ﹤0.01% 1352
2021
Q3 		– Sell
-12,806
Closed -$2.87M – 2621
2021
Q2 		$2.87M Buy
+12,806
New +$2.42M ﹤0.01% 1306

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Macquarie Group's BNTX Position: Q4 2025 in Review

Macquarie Group sold out of BioNTech (BNTX) in Q4 2025, closing a stake of 231,461 shares — an estimated $22.8M sold.

Macquarie Group first reported a position in BNTX in Q2 2021 and held it in 17 quarters. The position peaked at $26.8M in Q4 2024. 284 funds tracked by Wall St. Rank hold BNTX as of Q4 2025.

  • Macquarie Group reported no remaining BioNTech position as of Q4 2025 after selling out during the quarter.
  • Macquarie Group sold 231,461 BioNTech shares in Q4 2025, an estimated $22.8M.
  • Macquarie Group first reported a position in BioNTech in Q2 2021 and held it in 17 quarters.
  • Macquarie Group's BioNTech position peaked at $26.8M in Q4 2024.
  • 284 funds tracked by Wall St. Rank held BioNTech as of Q4 2025.

Based on Macquarie Group's 13F filing for Q4 2025, filed 13 Feb 2026.